ArticleCancers2022

A Patient-Specific Fracture Risk Assessment Tool for Femoral Bone Metastases: Using the Bone Strength (BOS) Score in Clinical Practice.

Florieke Eggermont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.